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ABSTRACT
Diet Induced Alteration of the Murine Intestinal Microbiome After
Antibiotic Ablation
Adam Irvin
Background and Objective
We detected a dominant non-cultivatable gram-positive coccobacillus
associated with cultivatable yeast in feces of mice treated with a cocktail
of broad-spectrum antibiotics while being fed a partially defined mouse
chow that is commonly used for nutritional studies. The goal of this
study was to determine the identity of the non-cultivatable grampositive coccobacillus.
Methods
Fecal samples were analyzed by Gram stain, quantitative flow
cytometry, next generation sequencing of the V3 or V4 regions of the
16S rRNA gene, fluorescence microscopy, and sequence analysis of the
tuf gene, which can distinguish among Streptococcus and Staphylococcus
genera.
Results
Fecal samples from antibiotic-treated mice displayed a ten-fold decline
in bacterial cell number. High-throughput sequencing of the variable
regions of the 16S rRNA gene and tuf gene sequencing identified the
major phylotype as Lactococcus. Lactococcus did not grow from fecal
cultures, although Enterococcus casseliflavus did grow, which was a
confounding finding. The mouse chow was heavily contaminated with
non-viable Lactococcus. Appearance of intestinal yeast was dependent
on the specific chow, although yeast was not detected in the chow.
Conclusion
Dead bacteria in food can modulate the intestinal microbiome. Whether
and how food-derived dead bacteria alter intestinal physiology needs to
be determined.
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GENERAL INTRODUCTION
From birth until death, microorganisms, especially bacteria, coexist with
humans in a mutualistic relationship. The host provides nourishment

and a suitable environment for the bacteria, and the bacteria play a role
in establishing and maintaining a healthy immune system[1], prevent
colonization of pathogens[2] and contribute to host nutrition by

synthesizing vitamins (i.e. vitamin K and biotin) and metabolizing non-

digestible starches[3-5]. There are an estimated 1014 bacterial cells (at
least an order of magnitude more than the total number of our own

cells)[6-7] that colonize the human body, with the majority residing in
areas that include the skin surface, oral cavity, nasal cavity,

genitourinary system and the gut{8}. The compilation of microorganisms

and their collective genome within a niche is referred to as a

microbiome[9-11], which can consist of bacteria, viruses, fungi and
Archaea[12-14].

The intestinal microbiome has been identified as a key player in several
processes that include; metabolic, nutritional, physiologic and

immunologic[15]. The gut is sterile until the moment of birth, at which
1

point the intestinal microbiome becomes established. The microbiome
expands and increases in diversity through adolescence and into
adulthood, at which point the population and diversity begins to
decline[16].

At birth, the intestinal microbiome can be influenced by means of

delivery. A study found that babies delivered by vaginal birth had a

significantly higher population of Actinobacteria than children delivered

by caesarean section[17]. However, the microbiome quickly changes with
the introduction of nutrients.

Intestinal microbiomes of newborns are greatly influenced by the

source of nourishment they receive. Infants that are breast-fed have a
larger population of Actinobacteria when compared to formula-fed
infants, and have nearly a two-fold increase in total number of

bacteria[18]. With the introduction of solid foods the microbiome takes a
dramatic shift, and Actinobacteria percentages drop significantly while

Bacteroidetes and Firmicutes become the dominant phyla[19].

2

The trend of a microbiome that is primarily dominated by an equal ratio
of Bacteroidetes and Firmicutes continues through adolescence and into

adulthood. In adulthood, Firmicutes become the primary phylum in

average, healthy adults microbiome. This trend continues throughout
life as the number of bacteria and diversity decline[20].

The human gut normally possesses one of the densest populations of
bacteria found on Earth[21-22]. Populations of bacteria within the gut

have been enumerated at levels reaching 1012 cells per ml of intestinal

content with over 10,000 different phylotypes identified[22]. Molecular

approaches with Next-gen sequencing have detected that approximately
only 1% of bacteria residing in the gut can be recovered by culturebased approaches[23].

A variety of factors play a role in establishing and maintaining the gut
microbiome to include: age, diet, health, geographic location and

genetics[24-30]. Dysbiosis within microbiomes have been linked to
certain diseases: cancer, obesity, diabetes, atherosclerosis and
inflammatory bowel disease[31-32].
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Antibiotics introduced into the intestinal tract disrupt the microbiome

by suppressing the total bacterial population and diversity in a variety
of ways. Broad-spectrum antibiotics are often prescribed to treat

infections to ensure eradication of the pathogenic bacteria. In the past
little regard was taken to the effects that these antibiotics have on the
normal microbiota, and how they could promote colonization of

pathogens, such as Clostridium difficile. One study has shown that
antibiotics introduced to infants are capable of modulating the

microbiome even 8 wks after terminating antibiotic use[33].

Antibiotic use became the standard of care for treating infections in the
1940s and has been widely used since. They have played a large role in

extending human longevity; however antibiotic-resistant pathogens

have wreaked havoc on health care and patients for at least the past two

decades[34]. However, within the last decades with the improvements to
high-throughput sequencing, the true significance of the microbiota
within the gastrointestinal tract suppressing the colonizing of
pathogens is being realized.

4

Murine models of intestinal microbiome disruption are often used to
demonstrate the effects of antibiotics. Antibiotics are typically

administered either through drinking water or by oral gavages, and are
used to selectively target groups of bacteria. Numerous cocktails of
antibiotics have been used to either ablate the gut flora of mice to
present a sterile gut environment or to target certain genera of

bacteria[35-41]. One recipe of antibiotics that is commonly used in studies
is a combination of vancomycin, ampicillin, neomycin and

metronidazole[36, 39, 42]. The metronidazole targets anaerobic bacteria,

neomycin is effective against Gram-negative bacteria, vancomycin is

highly effective against Gram-positive organisms, and the ampicillin

targets the remaining bacteria and has broad spectrum capabilities. In
these studies, it is evident that the antibiotics suppress either the

selected commensal bacteria or ablate nearly the entire microbiome. An
alternative approach to studying the microbial ecology of the small

intestine is through the use of germ-free mice. One such study showed

colonizing germ-free mice with known commensal bacteria was capable
of preventing introduced pathogens from colonizing[43].

5

Prebiotics and probiotics have been studied for beneficial effects as

supplements for the commensal bacteria in the gut. Prebiotics, such as

cellulose and tagatose, are non-digestible food ingredients that

modulate the gastrointestinal environment to promote the growth of

select bacteria. A prebiotic mixture of galactooligosaccharides, brand

name Bimuno, has demonstrated potential relief to patients suffering

from inflammatory bowel disease. Probiotics are commensal bacteria,

such as Lactobacillus and Bifidobacterium, which are commonly used to

help augment existing commensal bacteria within the gut. There are

conflicting reports on the clinical efficacy of probiotic use; however a

ground-breaking study focused on fecal transplantations from healthy

donors to treat patients with Clostridium difficile infections[44]. The

results were remarkable, with greater than 95% of patients cleared of

infection without a subsequent infection. Fecal transplants are currently
being researched as potential treatments.

Apart from bacteria, yeast and Archaea play a role as commensal
organisms within the human intestinal microbiome. It has been

documented that yeast can propagate in response to suppressing
bacterial growth through antibiotic-treatment. Interestingly, the
6

lineage of the yeast changes under long-term antibiotic treatment[36].
Archaea, such as Methanobrevibacter smithii and Methanosphaera

stadtmanae, are considered normal microbiota of the human intestines

and have an essential role.[45] As anaerobic bacteria metabolize pectin
and other complex sugars, hydrogen and methanol are released as
byproducts. Both hydrogen and methanol reduce the efficiency of

fermentation, and these Archaea methanogens use both hydrogen and
methanol as a source of energy. Although Archaea has not been

identified to exist within the murine gut, given the similarities of

composition and environment between the human and murine gut, it is
reasonable to believe that Archaea could exist within the murine gut as
a commensal organism.

The present study was undertaken to examine the role of diet in

affecting the intestinal microbiome; particularly in the context of

antibiotic-induced perturbations in an intestinal ecosystem. We initially

wanted to add quantitative analysis to previously reported studies that
relied on culture methods[46] or qPCR[36] to quantify perturbation of

the16S gene in studies of the microbiome. We also wanted to explore
the existence of Archaea within the murine intestinal microbiome.
7

MATERIALS AND METHODS
Mice
Female C57BL/6 mice, aged 6 weeks old were obtained from The
Jackson Laboratory (Bar Harbor, ME). The mice were randomly

separated into two groups and housed in the Health Sciences Center

Animal Care Facility 5 mice per cage under approved protocol number
12-0506.3. Upon arrival the mice were placed on either a controlled

diet (referred to as Open Source chow), D12450B from Research Diets
Inc (New Brunswick, New Jersey) or on 2018 Teklad Global 18%

Protein Rodent Diet chow ad libitum, dependent upon the experiment.
The mice were allowed to acclimate for 5 days prior to use.
Antibiotics
The antibiotics vancomycin (0.5 mg/mL), ampicillin (1.0 mg/mL),

metronidazole (1.0 mg/mL) and neomycin (1.0 mg/mL) were dissolved
into filtered (0.22 µm), sterile water and delivered to mice in light-

protected water bottles (35). Aspartame (3.75mg/mL) was also added to

the antibiotic containing water to make the water palatable for the mice.
8

All antibiotics were purchased through Sigma Aldrich (St Louis, MO).
The vancomycin, ampicillin and neomycin were United States

Pharmocopeia (USP) certified, and metronidazole was traceable to USP.
The antibiotic water was made fresh every 48 hours, due to the loss of

efficacy of the ampicillin in solution. Based on the minimum inhibitory
concentration (MIC) against a laboratory strain of E. coli, it was

determined that ampicillin lost 90% of its efficacy within 24 hours in

solution. Due to the nature of the prolonged study and to recapitulate

the results from Hildebrandt et al. [22], the decision to change the water
at 48 hour intervals was made.

Sample Collection and Processing
To ensure that fresh fecal pellets were collected, mice were placed into
sterile, empty pipette tip boxes for up to 3 minutes. The mice were

under direct observation the entire time to ensure that once a fecal

pellet was expelled, mice were placed back into their home cages and

the pellets placed into 1.5 mL Eppendorf tubes. If the fecal pellets were

contaminated by urine, the samples were discarded. The samples were
weighed and then emulsified in 1 mL of sterile water using a Pellet

Pestle Motor from Kimble Chase Kontes (Vineland, NJ). The samples
9

were then centrifuged at 800 x g for 1 minute to remove fecal debris.

Five hundred uL of the supernatants were diluted in 500 uL of sterile
water in a fresh 1.5 mL Eppendorf tubes.
DNA Isolation
DNA was isolated from murine fecal pellets by processing fecal pellets

as described above and purifying the DNA using QIAamp DNA Stool Mini
Kit from Qiagen (Valencia, CA, USA) following the manufacturer’s

instructions. Genomic DNA was stored at - 20°C.
PCR and Fragment Purification

The PCR primer sequences, the conditions for amplification of the V3

region of the 16S ribosomal RNA gene, and multiplexed DNA sequencing
strategy were as described in Bartram et al.[47] unless otherwise

indicated. The PCR primers for the V4 region of the 16S ribosomal RNA
gene were as described in Caparoso et al.[48]. High-pressure liquid

chromatography purified PCR primers for the V3 region were obtained
from Integrated DNA Technologies (Coralville, IA, USA) and the V4

region primers were obtained from Invitrogen (Grand Island, NY, USA).
Bacterial DNA was amplified using an AccuPrime PCR Kit (Invitrogen
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Life Technologies, Grand Island, NY, USA) on a Techne Genius Model

FGEN02TP Thermal Cycler using the following conditions: 95°C for 6
minutes denature; 95°C for 2 minutes, 50°C for 2 minutes, 72°C for 2

minutes 30 cycles; 72°C for 4 minutes extend. Each reaction contained 1
U TAQ polymerase, 5 μl 10x buffer 1(600 mM Tris-SO4 (pH 8.9), 180

mM (NH4)2SO4, 20 mM MgSO4, 2 mM dGTP, 2 mM dATP, 2 mM dTTP, 2
mM dCTP, thermostable AccuPrime™ protein, 10% glycerol), 20 μM

forward primer, 20 μM reverse primer, and up to 60 ng DNA in a total
volume of 50 μl. PCR reactions were performed in triplicate and

reaction products were pooled prior to purification. Because there was

a low concentration of DNA in the samples from the treated mice, it was
necessary to perform 30 cycles of amplification to obtain sufficient
material to view on gels. Pooled PCR products were purified by

electrophoresis through 2% agarose in Tris/acetate/EDTA gels and the

bands corresponding to approximately 300 base pairs for V3 and bands

corresponding to approximately 400 base pairs for V4 were excised and
purified using a QIAquick Gel Extraction Kit (Qiagen, Valencia,CA, USA)

according to the manufacturer's directions. The V3 and V4 regions both

vary in length by about 30 base pairs among different species of

bacteria, and the sequences obtained and analyzed in this study showed
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similar size variability. The amplicon of the V3 region ranged from 296
to 327 base pairs, of which 160 base pairs were the primer. The

amplicon of the V4 region ranged from 373 to 402 base pairs, of which
172 base pairs were the primer.

PCR Amplification with Genus Specific Primers
Bacterial DNA was amplified with either on a Techne Genius Model

FGEN02TP Thermal Cycler using the following conditions: 95°C for 6

minutes denature; 95°C for 2 minutes, 50°C for 2 minutes, 72°C for 2

minutes 20 cycles; 72°C for 4 minutes extend. Each reaction contained 1

U TAQ polymerase, 5 μl 10x buffer 1(600 mM Tris-SO4 (pH 8.9), 180

mM (NH4)2SO4, 20 mM MgSO4, 2 mM dGTP, 2 mM dATP, 2 mM dTTP, 2
mM dCTP, thermostable AccuPrime™ protein, 10% glycerol), 20 μM

forward primer, 20 μM reverse primer, and up to 100 ng DNA in a total

volume of 50 μl. The Lactococcus[61] and Enterococcus[62] specific
primers are listed in Table 3.

Illumina HiSeq High Throughput (HT) Sequencing
Libraries were sequenced in a 2 x 125 bp paired-end strategy on an
12

Illumina HiSeq1000, so that the forward and reverse reads could be

assembled into a single contig. Indexed libraries were pooled so that 12

libraries were sequenced in each lane of the flow cell. Eight pmols of the

pooled libraries were clustered onto an Illumina v2 sequencing flow cell

using an Illumina cBOT. Reads were converted from Illumina bcl format

to fastq format and separated into bins based on exact match to the

index using CASAVA 1.8.2 (Illumina, San Diego CA, USA). The Illumina
HiSeq was performed at Marshall University (Huntington, West

Virginia.) Sanger sequencing was performed by the Molecular Medicine
core facility at West Virginia University and MiSeq sequencing was
performed by the West Virginia University Genomics core facility.
HiSeq Data Processing
Sequence files were initially processed by removing sequences

corresponding to linkers and primers by automated batch processing

using scripts written in-house. In an effort to reduce artifacts generated
by sequencing errors, a strict quality filtering protocol was employed

that reduced the number of analyzed sequences to approximately 35%

of the total number of sequences generated. Nevertheless, an average of
more than two million high quality reads was obtained from each
13

sample. Quality filtering of DNA sequences was performed using the
following steps: 1) Sequences were first filtered by the Illumina

software to eliminate the poorest reads (Q score ≥ 30) and imperfect

primer matches. 2) The forward and reverse sequences were matched
to construct a sequence that spanned the entire region between the
primers with a program written in-house. The original Illumina

sequences were all 125 bases in length, which is where the run ended.

The pairing strategy overlaid the two 3’ ends starting with an overlap of
58 bases for the V3 region. The overlap window was extended one base

at a time to 89 bases until a perfect match was obtained in the overlap

region. Any pair of sequences that did not match at 100% identity in any
of the size windows was discarded. This step eliminated 56% of the
sequences, which overwhelmingly had the lowest quality scores. In

general, the sequence quality was better in the middle than at the end,

so this preferentially eliminated sequences with sequencing artifacts. 3)
Paired sequences with a Phred quality score of less than five were
discarded. This removed a few remaining low quality sequences,

especially any that had low quality in the regions between the primers
and the overlap. 4) The sequences were clustered by matching against
the Greengenes database, which is a curated collection of known
14

bacterial 16S sequences. Sequences that did not match any of the known
bacterial sequences with 97% identity were discarded. This removed

chimeras and most major PCR artifacts and represented approximately
5% of the total remaining sequences. Matching at 97% identity meant
that any single base PCR artifacts would be combined with the

corresponding authentic sequence (since the region is about 100 bases
long, up to three single base changes will be ignored). 5) The resulting

table of operational taxonomic units (OTUs) was filtered to remove any
sequences that appeared less than 150 times. Because of the length of
the V4 region, we were unable to perform the paired end strategy.

Scripts written in-house in biopython were used to convert the filtered
Illumina data to the FASTA format for analysis by QIIME for taxonomic
assignment and measurements of microbial diversity, but scripts to do

this are now part of QIIME. To process Illumina generated files in QIIME,

the file headers were changed to begin with ‘ >sample_number’ where ‘

sample’ is the sample number and ‘ number’ is the number of the

sequence in the file. All of the sequences were then combined into one
file for analysis with QIIME.
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QIIME
All QIIME analyses were performed on a virtual server hosted by

Amazon Web Services using an existing QIIME image. The server had
the following specification: QIIME 1.8.0 EBS East XLARGE (ami-

438d5b2a). The following QIIME scripts were used during analysis and
default parameters were used unless otherwise noted: 1) ‘ pick_

reference_otus_through_otu_table.py’ matched sequences at 97%
sequence identity with OTUs associated with specific bacterial
phylotypes in the Greengenes database (4Feb2014); 2)

‘summarize_taxa_through_plots.py’ generated bar graphs of the relative
abundance of different taxa in each sample; 3) ‘ alpha_rarefaction.py’

generated alpha rarefication plots; 4) ‘ pick_rep_set.py’, ‘ align_seqs.py’ ,

‘ filter_alignment.py’ , and ‘ make_phylogeny.py’ were chained to

generate a phylogenetic tree of the OTUs.

Tuf Gene Analysis
The tuf gene encoding elongation factor Tu was amplified with the tuf

forward primer: (5’-CCAATGCCACAAACTCGT-3’) and the tuf reverse

primer (5’-CCTGAACCAACAGTACGT-3’) as described in Li et al. [49].
16

Cloning of the tuf gene was carried out using a TOPO® TA for

sequencing kit from Invitrogen (Grand Island, NY, USA) according to the

manufacturer´s instructions. The 830 bp tuf gene was amplified by PCR

using AccuPrime PCR Kit (Invitrogen Life Technologies, Grand Island,
NY, USA) on a Techne Genius Model FGEN02TP Thermal Cycler using
the following conditions: 95°C for 6 minutes denature; 95°C for 2

minutes, 50°C for 2 minutes, 72°C for 2 minutes 30 cycles; 72°C for 4

minutes extend. Each reaction contained 0.5 μl TAQ polymerase, 5 μl

10x buffer 1(600 mM Tris-SO4 (pH 8.9), 180 mM (NH4)2SO4, 20 mM

MgSO4, 2 mM dGTP, 2 mM dATP, 2 mM dTTP, 2 mM dCTP, thermostable
AccuPrime™ protein, 10% glycerol), 20 μM forward primer, 20 μM

reverse primer, and up to 60 ng DNA in a total volume of 50 μl. For
cloning, the amplified fragment was inserted into the pCR4-TOPO

plasmid (4.0 Kb). Electrically competent cells (E. coli TOP10) were

transformed with the insert-containing plasmids. The recombinant

clones were selected by growth on LB agar with ampicillin (100 µg/ml)
following incubation for 18 hrs at 37°C with 5% CO2. The presence of
the insert in E. coli TOP10 transformants was verified by colony PCR
using the tuf primers. Plasmids from transformants were extracted

using the Mini-Prep 96 from Macconnell Research [San Diego, CA, USA]
17

according to the manufacturer´s instructions. Five mL cultures grown in

Magnificent Broth with ampicillin were incubated overnight. 2 mL of the
cultures were placed in each well and applicator combs inserted. Lysis
tablets were then added and allowed to incubate at room temp for 15

mins. Purified DNA was then removed from the corresponding wells on
the back of the cartridge and the samples were sequenced by WVU
Genomics Core facility by capillary (Sanger) sequencing.

Flow Cytometric Detection and Quantification of Fecal Bacteria
Fifty uL of the suspensions from fecal pellets were diluted in 950 uL of
sterile 0.5% NaCl for a final dilution of 1/400. Utilizing Invitrogen’s

(Grand Island, NY, USA) Bacteria Counting Kit for flow cytometry, 1 μL
of SYTO BC stain was added to the diluent as well as 10 μL of 1 x 108

/mL of microspheres, per manufacturer’s instructions. Samples were
analyzed with a Becton Dickinson FACSCalibur using the following
settings: FSC E00 gain; SSC 350 voltage; FL1 412 voltage; FL2 550

voltage and FL3 650 voltage. A region was placed around the beads to
capture a quantity of 10,000 beads; another region was placed to

capture the number of bacteria that were counted in comparison to the
18

10,000 beads. WINMDI 2.8 software, (Joe Trotter, Scripps Research
Institute, La Jolla, CA) was used to analyze the flow cytometer data.
Fluorescent Microscopy
Fifty μL of the suspensions from fecal pellets were diluted in 950 μL
sterile 0.85% NaCl, either 1 μL of BacLight Red bacterial stain

(Invitrogen, Grand Island, NY, USA), 1 μL of SYTO 9 stain (Invitrogen,
Grand Island, NY, USA) , or 1 μL of both were added and samples

incubated for 15 minutes at room temperature in the dark. Ten μL of

sample was then placed on glass microscope slides, 1 drop of ProLong
Gold (Invitrogen, Grand Island, NY, USA) was added and a cover slip

applied. The slides incubated for 24 hours at room temperature in the
dark to allow the coverslip to seal in accordance with manufacturer’s
instructions, and were examined by confocal microscopy.

Metagenomics analysis
Predictive functional profiling of the microbiome was performed using
the 16S rRNA sequencing data and then running the following scripts

through the PICRUSt database:[50] 1) normalize_by_copy_number.py; 2)
19

predict_metagenomes.py; 3) categorize_by_function.py. QIIME

commands were then executed on the file: 1) summarize_taxa.py (with –
md_identifier=KEGG_Pathways flag); 2) plot_taxa_summary.py.

20

RESULTS
Gram stains of suspensions from fecal pellets from control mice
and antibiotic-treated mice
Suspensions of fecal pellets from both control and antibiotic-treated

mice were collected after two weeks of treatment and analyzed by Gram
stain. Samples from control mice displayed a very diverse population of

bacteria, which consisted of both Gram-positive and Gram-negative rods

and cocci and was consistent with normal gastrointestinal microbiota
(Fig 1A). Gram stains of samples from the antibiotic-treated mice

showed distinctly homogeneous Gram-positive coccobaccilli, as well as
some yeast (Fig 1B), suggesting that antibiotic treatment altered the
normal intestinal microbiota.

Quantitative flow cytometry performed on fecal pellets from
control and antibiotic-treated mice
Quantitative cell counts were performed on suspensions of fecal
bacteria by flow cytometry. Ten samples from each group were

analyzed and an approximate 1-log10 reduction in the number of

bacteria was found in the antibiotic-treated samples when compared to
21

the control samples (Fig 2A). As was observed on the Gram stains, the
control mice had a diverse population (Fig 2B) of bacteria as

determined by forward scatter, while the antibiotic-treated mice had a
homogeneous population (Fig 2C).

Fluorescent microscopy performed on fecal suspension to
determine cellular composition
To confirm that the Gram stain and flow cytometric assays were

detecting bacteria, samples were stained with dual fluorescent stains

(Fig 3A and B) and examined using confocal microscopy. A merged view
(Fig 3C) displays that the putative bacteria contain nucleic acid and
their cell walls are comprised of peptidoglycan.

Sequencing of V3 region of 16S rRNA from DNA extracted from
antibiotic-treated and control mice feces
Paired-end sequencing of the V3 region of the 16S rRNA gene was

performed to identify the Gram-positive coccobaccilli in the antibiotic-

treated mice, and characterize the fecal microbiomes of the treated and
non-treated mice. Figure 4 represents a graphic display of the

Organizational Taxonomic Units (OTU) table generated from QIIME, and
22

shows substantial increase in Lactococcus species in the antibiotictreated group when compared to the control group. Within the

antibiotic-treated group, there is a decrease in Bacteroidetes and nonLactococcus, Firmicutes. Although the Lactococcus is present in the

control group as well, it is in much smaller quantities when compared to
the antibiotic-treated samples.

Sequencing of V4 region of 16S rRNA from DNA extracted from
antibiotic-treated and control mice feces
Due to the length of the V4 region of the 16S rRNA gene, contigs could

not be generated as were with the V3 region because of only 1 or 2 base
overlaps. The V4 region sequencing (Fig 5) displayed a loss of

Bacteroidetes and an increase in Lactococcus in the antibiotic-treated

samples when compared to the control samples, albeit the changes were
not as dramatic in the V4 results as displayed in the V3 results. A small
percentage of Archaea was also detected in antibiotic-treated samples.
Culturing
Numerous attempts at culturing the coccobacilli that were observed by
Gram stain in the antibiotic-treated samples yielded predominantly
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overgrowth of yeast (Fig 6A). Upon closer examination, there were also
scant pinpoint, α-hemolytic colonies. These colonies were isolated (Fig
6B), DNA was extracted, and the entire 16S rRNA gene was PCR-

amplified and sequenced. Sequence analysis identified the alpha

hemolytic colonies as Enterococcus casseliflavus, not Lactococcus. The

inconsistency between the HT sequencing and culture results required
additional analysis.

Cloning of Tuf gene
Sequence variation in the tuf gene, a prokaryotic elongation factor, has

been previously used to differentiate species of Gram-positive cocci (Li

et al.[39] Therefore fecal DNA from antibiotic-treated mice was amplified
using degenerate tuf-specific primers, cloned, and sequenced.

14 of 14 samples yielded a 99% match with Lactococcus through BLAST.
These results confirmed the results from the V3 sequencing data.
Growth time point assay
After numerous unsuccessful attempts to grow Lactococcus from the
fecal samples from antibiotic-treated mice on a variety of bacterial

media, fecal samples from the antibiotic-treated mice were cultured in
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evaporated milk. Aliquots were removed at time 0, and every 8 hours of
incubation for a 24-hour period. DNA samples from each time point

were amplified using Lactococcus or Enterococcus specific primers. The

reactions resulted in an initial positive reaction for the Lactococcus with
no increase in the levels of PCR product through the 24-hour time

period, indicating that the Lactococcus was not replicating. However,

although the initial sample failed to amplify with Enterococcus specific
primers, weak positive results were detected at 16 hours and strong

positive observed at 24-hours (Fig 7A). Gram stains were performed on
the sample at 24 hours and demonstrated Gram-positive coccobaccili

detected and yeast in the culture (Fig 7B).
Examination of the chow

To identify the source of the Lactococcus, a 20 mg sample of the Open
Source Chow was processed in the same manner as the fecal samples

and Gram stained (Fig 8A). The Gram stain results of the Open Source
chow demonstrated that the chow was heavily contaminated with

Gram-positive coccobaccili, with no yeast observed. A sample of the

2018 Teklad Global 18% Protein Rodent Diet chow normally used in
HSC vivarium was then examined in the same manner as the Open
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Source chow and Gram stained (Fig 8B). No bacteria were visualized on
the Gram stain of the 2018 Teklad Global 18% Protein Rodent Diet

chow. To determine if the bacteria from the Open Source chow was

Lactococcus, PCR reactions were performed on both the Open Source

chow and the 2018 Teklad Global 18% Protein Rodent Diet chow with
both specific and universal primers for 16S rRNA (Fig 9). The results
demonstrated that both the 2018 Teklad Global 18% Protein Rodent
Diet chow and the Open Source chow contained DNA from bacteria,
however the Open Source Chow contained Lactococcus DNA.
Flow cytometric analysis of the chow
The Open Source and 2018 Teklad Global 18% Protein Rodent Diet

chows were analyzed by flow cytometry to compare the forward scatter
characteristics of bacteria in the chow with bacteria in the fecal samples
of antibiotic-treated mice. The Open Source chow had a distinct

bacterial population that resembled the fecal samples from the

antibiotic-treated mice (Fig 10A), while the 2018 Teklad Global 18%

Protein Rodent Diet chow lacked a distinct population (Fig 10B). A pure
culture of Lactococcus was analyzed for comparison (Fig 10C).
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Quantitative analysis revealed the bacterial cell count for the Open
Source chow to be 3 × 1012 per gram.
Live/Dead Analysis
To determine the viability of the Lactococcus present within the Open

Source chow, a Live/Dead analysis was performed using Invitrogen’s

LIVE/DEAD BacLight Bacterial Viability kit according to manufacturer’s
instructions. The analysis showed that the Lactococcus from the Open
Source chow was non-viable (Fig 11).

Effects of 2018 Teklad Global 18% Protein Rodent Diet chow
To determine the differences of gastrointestinal microbiomes when the
mice were placed on different chow, 15 additional C57BL/6 mice were
acquired from Jackson Laboratory. Upon receipt, the mice were

handled in the exact manner as before with the exception of placing the
mice on 2018 Teklad Global 18% Protein Rodent Diet chow rather than
the Open Source Diet. DNA extracted from fecal pellets from both

antibiotic-treated and control mice were amplified using V3 16S rRNA
primers and sequenced (Fig 12) using an Illumina MiSeq. The

antibiotic-treated mice produced an overwhelming dominance- >95%
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in all 5 mice- of a lactose fermenting Enterobacteriaceae. The short V3

regions of the V3 region of the 16S rRNA were unable to differentiate
between species of Enterobacteriaceae due to homology of the genus
within the V3 region. With the removal of the Open Source Diet no
Lactococcus was detected.

Metagenomic evaluation
PICRUSt Bioinformatics software was utilized to predict metagenomic
functions from the 16S rRNA sequencing data (Fig 13.) The most

notable change was a reduction in the content of genes predicted to play
a role in motility, which correlates with Lactococcus being a non-motile
organism.

Detection of yeast in feces is dependent on chow
Ingestion of the 2018 Teklad Global 18% Protein Rodent Diet chow not
only produced a dominant Enterobacteriaceae, but also failed to

produce yeast in the feces of antibiotic-treated mice. Yeast was not

detected in the feces of the mice that were fed 2018 Teklad Global 18%
Protein Rodent Diet chow and antibiotic treatment for 10 weeks by
either culture or Gram stain. Another group of mice that were on
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antibiotic treatment and fed the 2018 Teklad Global 18% Protein

Rodent Diet chow for 3 weeks and then converted to Open Source chow
for the remaining 7 weeks also produced the Enterobacteriaceae with
the absence of yeast. In comparison, the mice that were on antibiotic
treatment and the Open Source chow displayed yeast by culture and
Gram stain after 2 weeks. (Data not shown)
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Table 1. Yeast in feces of antibiotic-treated mice dependent on chow

Chow

Yeast

Open Source

Teklad Global

Teklad Global/converted to Open Source *

+
-

*Mice were fed Teklad Global chow for 3 wks and then converted to Open Source chow for
remaining 7 weeks
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Table 2. Sequences of primers used in the construction of libraries for
Illumina sequencing. Lowercase letters denote adapter sequences necessary
for binding to the flow cell, underlined lowercase are binding sites for the
Illumina sequencing primers, bold uppercase highlight the index sequences
and regular uppercase are the V3 or V4 region primers.[37]
Forward Primers Sequence (5’ to 3’)
V3_Fmod aatgatacggcgaccaccgagatctacactctttccctacacgacgctcttccgatctNNNNCCTACGGGAGGCAGCAG
V4_Fmod aatgatacggcgaccaccgagatctacactctttccctacacgacgctcttccgatctNNNNGTGCCAGCGCCGCGGTAA

Reverse Primers
V3_1R
caagcagaagacggcatacgagatCGTGATgtgactggagttcagacgtgtgctcttccgatctATTACCGCGGCTGCTGG
V3_2R
caagcagaagacggcatacgagatACATCGgtgactggagttcagacgtgtgctcttccgatctATTACCGCGGCTGCTGG
V3_3R
caagcagaagacggcatacgagatGCCTAAgtgactggagttcagacgtgtgctcttccgatctATTACCGCGGCTGCTGG
V3_4R
caagcagaagacggcatacgagatTGGTCAgtgactggagttcagacgtgtgctcttccgatctATTACCGCGGCTGCTGG
V3_5R
caagcagaagacggcatacgagatCACTGTgtgactggagttcagacgtgtgctcttccgatctATTACCGCGGCTGCTGG
V3_6R
caagcagaagacggcatacgagatATTGGCgtgactggagttcagacgtgtgctcttccgatctATTACCGCGGCTGCTGG
V3_7R
caagcagaagacggcatacgagatGATCTGgtgactggagttcagacgtgtgctcttccgatctATTACCGCGGCTGCTGG
V3_8R
caagcagaagacggcatacgagatTCAAGTgtgactggagttcagacgtgtgctcttccgatctATTACCGCGGCTGCTGG
V3_9R
caagcagaagacggcatacgagatCTGATCgtgactggagttcagacgtgtgctcttccgatctATTACCGCGGCTGCTGG
V3_10R
caagcagaagacggcatacgagatAAGCTAgtgactggagttcagacgtgtgctcttccgatctATTACCGCGGCTGCTGG
V3_11R
caagcagaagacggcatacgagatGTAGCCgtgactggagttcagacgtgtgctcttccgatctATTACCGCGGCTGCTGG
V3_12R
caagcagaagacggcatacgagatTACAAGgtgactggagttcagacgtgtgctcttccgatctATTACCGCGGCTGCTGG
V4_13R
V4_14R
V4_15R
V4_16R
V4_17R
V4_18R
V4_19R
V4_20R
V4_21R
V4_22R
V4_23R
V4_24R

caagcagaagacggcatacgagatCGTACTgtgactggagttcagacgtgtgctcttccgatctGGACTACHVGGGTWTCTAAT
caagcagaagacggcatacgagatGACTGAgtgactggagttcagacgtgtgctcttccgatctGGACTACHVGGGTWTCTAAT
caagcagaagacggcatacgagatGCTCAAgtgactggagttcagacgtgtgctcttccgatctGGACTACHVGGGTWTCTAAT
caagcagaagacggcatacgagatTCGCTTgtgactggagttcagacgtgtgctcttccgatctGGACTACHVGGGTWTCTAAT
caagcagaagacggcatacgagatTGAGGAgtgactggagttcagacgtgtgctcttccgatctGGACTACHVGGGTWTCTAAT
caagcagaagacggcatacgagatACAACCgtgactggagttcagacgtgtgctcttccgatctGGACTACHVGGGTWTCTAAT
caagcagaagacggcatacgagatACCTCAgtgactggagttcagacgtgtgctcttccgatctGGACTACHVGGGTWTCTAAT
caagcagaagacggcatacgagatACGGTAgtgactggagttcagacgtgtgctcttccgatctGGACTACHVGGGTWTCTAAT
caagcagaagacggcatacgagatAGTTGGgtgactggagttcagacgtgtgctcttccgatctGGACTACHVGGGTWTCTAAT
caagcagaagacggcatacgagatCTCTCTgtgactggagttcagacgtgtgctcttccgatctGGACTACHVGGGTWTCTAAT
caagcagaagacggcatacgagatCAAGTGgtgactggagttcagacgtgtgctcttccgatctGGACTACHVGGGTWTCTAAT
caagcagaagacggcatacgagatCCTTGAgtgactggagttcagacgtgtgctcttccgatctGGACTACHVGGGTWTCTAAT
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Table 3. Genus specific primers used to identify Lactococcus and Enterococcus.
Lactococcus specific primers (5’ to 3’)
GTACTTGTACCGACTGGAT
LacF
GGGATCATCTTTGAGTGAT
LacreR

Enterococcus specific primers (5’ to 3’)
Ent1
TACTGACAAACCATTCATGATG
Ent2
AACTTCGTCACCAACGCGAAC
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A

B

Figure 1. Gram stains from fecal pellets from control mice (A) and
antibiotic-treated mice (B). In (A) there is a very diverse population of
both Gram-positive and Gram-negative organisms both rods and cocci.

Samples from antibiotic-treated mice (B) showed distinct homogeneous

Gram-positive coccobaccilli, as well as yeast. Photos are taken at 630X.
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A

B

C

Figure 2. Quantitative flow cytometry performed on suspension
from fecal pellets from control and antibiotic-treated mice on Open
Source diet. Samples from 10 mice in each group were analyzed and

displayed an average of a 1-log10 difference in bacterial load (A). A

heterogeneous population of cells is displayed in the control sample (B),
when compared to the antibiotic-treated sample (C), which displays a
distinct homogenous population of bacteria. (i) bacterial cells

population, (ii) microspheres population, (iii) debris.
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A

B

C

Figure 3. Fluorescent microscopy of fecal suspensions stained for
bacterial identification. Utilizing a dual stain; Syto 9, which stains the
nucleic acid green (A), a peptidoglycan stain that fluoresces red (B) and
then merging (C), confirmed that the cells contained DNA and

peptidoglycan. Photos are taken at 630X.
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1 NT
2 NT
3 NT
4 NT
5 NT
6 NT
1 ABX
2 ABX
3 ABX
3 ABX BB
4 ABX
5 ABX
6 ABX
6 ABX BB
7 ABX
8 ABX
8 ABX BB
9 ABX
Figure 4. Taxonomic assignment of phylotypes found in feces from
control and antibiotic-treated mice at the class level from V3 region
16S rRNA sequencing analysis. The total height of the bar represents

100% of the assigned sequences after quality filtering, and the height of
the individually colored bars represents the percentage of the class of

organisms. The expansion of Lactococcus within the antibiotic-treated

group is shown, while they also lose a large percentage of other Firmicutes

and Bacteroidetes. The control mice had a small percentage of Lactococcus,
but displayed a larger heterogeneity of bacterial population.
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Figure 5. Taxonomic assignment of phylotypes found in feces from
control and antibiotic-treated mice at the class level from V4 region
16S rRNA sequencing analysis . The total height of the bar represents

100% of the assigned sequences after quality filtering and the height of the
individually colored bars represents the percentage of the class of

organisms. The expansion of Lactococcus within the antibiotic-treated

group is still present, but not near the percentages as seen with the V3

data (Fig 4.) A loss of Bacteroidetes was still observed, however a decrease
in non-Lactococcus Firmicutes was not detected with the V4 sequencing

data.
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A

B

Figure 6. Cultures of feces from antibiotic-treated mice. Aerobic

cultures of the fecal pellets from the antibiotic-treated mice yielded an
abundant growth of yeast (A). Upon closer examination, there were

pinpoint α-hemolytic colonies that were subcultured for isolation on

new 5% sheep blood agar plate (B).
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A

B

Figure 7. Culturing of mouse fecal pellets and growth time point
assay. A 24-hour growth rate, time point assay was performed and the

growth of Lactococcus and Enterococcus were compared in culturing in

condensed milk. PCR amplification (A) was performed with bacteria-

specific primers at four separate time points; 0, 8 hours, 16 hours and
24 hour time points. Results indicate that the Lactococcus is present

initially but never propagates, and Enterococcus is detected at 16 hours

with an increase of PCR product at 24 hours. A Gram stain of the milk at
24 hours (B) displays Gram-positive cocci and yeast.
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A

B

Figure 8. Gram stain analysis (A) of Open Source and 2018 Teklad
Global 18% Protein Rodent Diet chow (B). The Gram stain displays
homogenous, Gram-positive coccobacilli in the Open Source diet that

resembles the organism from the fecal samples, whereas no bacterial
cells were observed in the 2018 Teklad Global chow.

40

Lacto Open Source chow

Lacto Teklad Global chow

Lacto Positive Control

Lacto Negative Control

V4 16S Open Source chow

V4 16S Teklad Global chow

V4 16S Positive Control

V4 16S Negative Control

Figure 9. PCR analysis demonstrates Lactococcus DNA present in
the Open Source Diet chow. The Open Source Diet chow and the 2018
Teklad Global chow were emulsified in sterile, distilled water and PCR

reactions were performed for 16S rRNA as well as Lactococcus specific

primers.
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A

B

C

Figure 10. Flow cytometric analysis of chow. Open Source Diet (A)

has a distinct bacterial population that resembles the fecal samples of

the antibiotic-treated mice (see Fig 2B) and this population is absent in

2018 Teklad Global chow (B). An analysis on a purified culture of
Lactococcus is shown in (C) for comparison.
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A

B

C

Figure 11. Viability analysis of chow via flow cytometry.
Invitrogen’s Live/Dead kit for bacteria utilizes Syto9 and propidium

iodide (PI) to elicit different staining characteristics between cells that
have an uncompromised cellular wall versus cells that are non-viable

and have perforations within the cell wall. If the cell wall has been

compromised the PI will quench the Syto9 and present a homologous

population, as seen in the E. coli cells fixed with 4% paraformaldehyde

(A). A dual population will be seen in viable cells that maintain their cell
walls, as seen in the sample of cultured Lactococcus (B). When the Open

Source chow is examined (C) there is a loss of the dual population,

identifying that the bacterial cell wall has been compromised and the
cells are not viable.
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Figure 12. Taxonomic assignment of the GI microbiome after
sequencing V3 region of 16S rRNA sequencing from antibiotic-treated
and control mice fed 2018 Teklad Global chow. The total height of the
bar represents 100% of the assigned sequences and the height of the
individually colored bars represents the percentage of the order of
organisms.
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Figure 13. Metagenomic analysis. Predictive metagenomic functions
were applied through PICRUSt bioinformatics software. The most

notable change between the antibiotic-treated and control group was in

motility, which correlates with Lactococcus being a non-motile
organism.
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Figure 14. Quantitative flow cytometry performed on suspension
from fecal pellets from control and antibiotic-treated mice on
Teklad global chow. Samples from 3 mice in each group were

analyzed and displayed an average of a 2-log10 difference in bacterial

load. The average cell count of the control group was 5.3×106 and the
antibiotic-treated group was 5.9×104 respectively. A heterogeneous
population of cells is displayed in the control sample (A), when

compared to the antibiotic-treated sample (B). Of note, most of the cells
counted in the antibiotic-treated sample (B) appear to be debris.
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DISCUSSION
Preliminary studies in this project were undertaken to examine the role
of diet in affecting the intestinal microbiome; particularly in the context
of antibiotic-induced perturbations in an intestinal ecosystem. We

initially wanted to add quantitative analysis to previously reported
studies that relied on culture methods[41] or qPCR[34] to quantify

perturbation of the 16S gene in studies of the microbiome.

Quantitative flow cytometry revealed an average of a 1-log10 decrease in
bacteria in the fecal samples from antibiotic-treated mice when

compared to the control fecal samples. This result conflicts with

previously reported 2 to 4-log10 decreases with qPCR[36, 42]. A possible

explanation for this disparity is variation in the number of 16S rRNA
gene copies that each bacterial organism possesses, the number of

copies can vary from 1 to 15 with an average of 7.[43] Thus, if remaining
bacteria have a disproportionately low copy number of 16S gene then
this could account for the discrepancy.
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Flow cytometric analysis of fecal suspensions from antibiotic-treated

mice showed a homogenous population that was staining with the DNA
stain SytoBC, and by forward scatter measurement were within the

same parameters of known bacterial cells. Further, Gram stains of fecal
suspensions from the antibiotic-treated mice yielded a morphologic
picture dominated by Gram-positive coccobaccilli. When fecal

suspensions from both antibiotic-treated and control samples were

diluted to equal concentrations based on the flow cytometry data, the

bacterial populations appeared equivalent in number by Gram stain in

all observed fields. This result conflicted with the 2 to 4 log10 difference
that was previously reported. This was an unexpected finding given the
type of antibiotics used in the system; the metronidazole should

eliminate the anaerobic bacteria, neomycin is effective against Gram-

negative bacteria, vancomycin is highly effective against Gram-positive

organisms, and the ampicillin should eradicate the remaining bacteria
due to it’s broad spectrum capabilities. Multiple attempts at culturing
the organism aerobically, anaerobically and microaerophically were

essentially negative, with the exception of the growth of yeast (that was

present in low numbers in the Gram stains) and very low numbers of

other colonies, which conflicts with the Gram stain and flow cytometry
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data. The potential explanations included: 1) the Gram-positive

coccobaccillus is a fastidious bacteria that was highly antibiotic

resistant; 2) the organism was Archaea; 3) material identified as a

microorganism by flow cytometer and Gram stain was actually debris;
4) the Gram-positive organism was dead.

The idea that the organism could be Archaea was provocative since

Methanobrevibacter smithii is known to colonize the human gut [44], but
to our knowledge it is unknown if they reside within the murine gut.

However, PCR analysis of the fecal suspensions of the antibiotic-treated

mice failed to amplify with Archaea specific primers (data not shown),
and fluorescent staining for both peptidoglycan and DNA provided

further evidence that the putative cells were bacteria.

PCR amplification was carried out at 30 cycles to ensure adequate
concentrations could be recovered to generate the libraries. PCR

reactions were performed with equivalent amounts of DNA quantified
by nanodrop, however it is impossible to distinguish between mouse
DNA and bacterial DNA in the measurement.
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High-throughput sequencing was performed on the fecal suspension to
compare the gut microbiome from the antibiotic-treated mice to the

control mice fed Open Source chow. Sequence analysis of both the V3

and V4 regions of the 16s rRNA gene indicated an expansion of

Lactococcus. The increase in Lactococcus was more evident in analysis of
the V3 region; however there was still an increase when the V4 region

was analyzed from the antibiotic-treated samples as well. The presence

of Lactococcus was confirmed by PCR amplification of fecal DNA with
Lactococcus specific primers. Therefore, based on morphological

determinants, high-throughput sequencing, and PCR performed with

specific primers, we concluded that the organism present in the feces of
the antibiotic-treated mice was Lactococcus. This result is consistent

with the findings presented by Dollive et al.[36] However, Lactococcus is

not a fastidious organism so it should have been readily cultivated, and
although previous studies have identified vancomycin resistant strains
of Lactococcus[53] an ampicillin resistant strain has not yet been

identified.
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The differences in the sequencing analysis between the V3 and V4 (Fig 4
& 5) regions can be explained by the length of product, the length of the

V3 product allowed us to overlap reads and create contigs, where the V4
region was too long and the sequence analysis was created from single
strand reads. The numbers at the bottom of the graphs correlate with
the mouse number and NT refers to the control group, no antibiotic

treatment given and the ABX is the antibiotic-treated group. For both

the V3 and V4 sequence runs the same number of samples were

processed, however some of the samples failed to produce adequate
reads due to various reasons.

Repeat culturing of the feces of the antibiotic-treated mice revealed

scant, pinpoint α-hemolytic colonies mixed in with the yeast, which we
initially surmised was Lactococcus. Significant efforts to enrich this

bacterium in Lactococcus-specific media (M17 agar supplemented with

10% sucrose and 0.5% glucose) were fruitless, and Sanger sequencing

of the 16S gene amplified from purified colonies identified the organism
as Enterococcus casseliflavus, not Lactococcus. Reexamination of the

sequences from the high-throughput sequencing data confirmed that a
very small percentage of Enterococcus within the fecal suspensions of
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the antibiotic-treated mice was detected. Nevertheless, comparison of
the previous V3 and V4 sequences in the high-throughput data that

were identified as Lactococcus did not match the V3 or V4 region of the

16S gene from the Enterococcus isolates. Previous studies have reported
that some species of Enterococcus have been shown to be resistant to

vancomycin and ampicillin[53-55], and follow-up testing on the isolates

from the fecal samples from the antibiotic-treated mice found the

Enterococcus strain to be resistant to vancomycin and intermediate to
ampicillin (data not shown). Thus we were forced to resolve the

seemingly incongruous dilemma of whether the organism that is
observed by Gram-stain and flow cytometry is Lactococcus or

Enterococcus, and if it was Lactococcus why did it not grow in culture.
A previously published study identified a region within the bacterial

elongation factor tuf gene that was capable of differentiating between

members of Enterococcus and Lactococcus.[49] Therefore, tuf gene

sequencing of DNA from fecal suspensions from antibiotic-treated mice
was performed, and 100% yielded a match for Lactococcus. Now

convinced that the organism in question was Lactococcus, we were still
perplexed that it would not grow. Studies have shown that both
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Lactococcus and Enterococcus will propagate in milk[55, 58], so a growth
assay was established using the milk as a medium and feces from

antibiotic-treated mice as the inoculum. It was determined that the

Enterococcus was propagating in the milk, however Lactococcus DNA

that was detected initially failed to produce an increase in intensity by

PCR throughout 24 hours of culture. Thus, we concluded that the

Lactococcus present in the feces was non-viable, but the source was still
unknown.

The possibility that the Lactococcus was a contaminant in the Open
Source chow prompted the examination of the chow. Gram stains

revealed that the chow was contaminated with Gram-positive
coccobaccilli, and PCR analysis confirmed the organism to be

Lactococcus. Cultures of the food yielded no growth, so it was concluded
that the bacteria were non-viable. A quantitative flow cytometric

evaluation of the Open Source chow determined a bacterial count of

3×1012 bacteria/g of chow. With an average daily consumption of 4.5 g
of chow/per mouse, the mice were consuming an average of 1.4×1013

non-viable Lactococcus per day. An average of 1.1×1010 Lactococcus

cells/g of feces was recovered from the antibiotic-treated mice, with an
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average of ~100 mg of feces occupying the intestines at any given time
that would account for 1012 Lactococcus cells residing within the

intestines. Our bacterial counts conflict with Dollive et al.[36] previously

reported 5×104 bacteria/per fecal pellet; one potential explanation is
that the DNA within the dead Lactococcus is degrading and lacks the

stability to amplify by qPCR, however the SytoBC stain is still capable of
binding to the DNA making detection by the flow cytometer possible.
Given this scenario, the dead Lactococcus could be though of as an

empty peanut shell that facilitates transport of its degrading DNA

throughout the intestinal tract. Interestingly, we discovered

proportional levels of Lactococcus present throughout the intestinal

tract, to include the small intestines just above the ilealcecal junction,

which is normally has a much lower concentration of microorganisms at
an average of 104 bacterial cells /g[57].

Lactococcus is widely used in the dairy industry because of its

homofermentor capabilities[58]; it solely produces lactic acid as it

metabolizes glucose. Lactococcus acidifies milk rapidly and prevents

the overgrowth of other bacteria that would cause spoilage[58]. One of

the main sources of protein in the Open Source chow is casein, which is
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derived from mammalian milk. It is quite possible that the Lactococcus
in the chow is from the acidified milk that is used to introduce casein

into the finalized pelletized chow. Casein is also present in Open Source
Hi-fat diets that are commonly used in nutritional studies, which

explains results from earlier studies with the presence of Lactococcus-

like bacteria in fecal samples from antibiotic-treated mice fed a high-fat

diet (Cuff et al. unpublished).

After the discovery of the Lactococcus in the Open Source chow we

wanted to repeat the microbiome analysis of the V3 region with the

mice on another chow. Teklad Global 2018 is the normal chow used in
the WVU Health Sciences vivarium, and was confirmed to be negative

for Lactococcus. Firmicutes and Bacteroidetes represented the majority
of the bacterial population in the control mice samples that were fed

Open Source chow; however with the Teklad Global chow there was a

larger percentage of Bacteroidetes and a smaller percent of Firmicutes

than with the Open Source chow. These data reflect the removal of the
Lactococcus (which is in the Firmicute order) from the chow. The
antibiotic-treated samples had a >95% population of a lactose

fermenting Enterobacteraceae that was identified as Escherichia coli by
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Vitek analysis performed in the laboratory at Ruby Memorial hospital,

Morgantown, WV. Our findings coincide with Hill et al.[42], in respect to
an increase in Enterobacteraceae in mice that are treated with

antibiotics administered through drinking water, and no Lactococcus
discovered when diet did not contain casein.

The antibiotic-treated fecal samples also showed a loss of bacterial

motility genes when predictive metagenomic analysis was performed
through PICRUSt, which is consistent with an increase in Lactococcus,

which is non-motile. Although in minuscule percentages, Archaea was
identified by sequencing the V4 region of 16S rRNA in the antibiotictreated mice.

Interestingly, there was no yeast recovered from the feces of the

antibiotic-treated mice that were fed the Teklad Global even after 10

wks of treatment. Another group of antibiotic-treated mice that were
fed the Teklad Global for 3 wks and were then converted to the Open

Source chow for the remaining 7 wks also failed to produce yeast in the
feces. However, yeast was recovered at day 7 of antibiotic treatment in
the feces of mice that were fed only the Open Source. Speculation as to
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why the mice that were fed the Teklad Global chow failed to grow yeast
from the feces is that the Teklad Global lacked the sucrose

supplementation that was included in the Open Source chow. The Open
Source chow consists of 35% sucrose, which yeast utilize as a source of

nutrients, especially Candida spp.[52] In the mice that were fed solely the

Open Source chow, we speculate that the addition of the sucrose

supported the growth of Candida and outcompeted antibiotic-resistant

bacteria from colonizing. We further speculate that the intestines

within the mice fed the Teklad Global chow from the beginning

supported the antibiotic resistant bacteria the opportunity to colonize
and flourish to outcompete the yeast once the Open Source chow was

introduced. An experimental approach to check if the dead Lactococcus
was promoting the growth of the yeast would be to fortify the Teklad
Global chow with dead Lactococcus and feed it to the mice.

Our results demonstrate that ingestion of chow contaminated with nonviable Lactococcus is capable of passage through the intestinal tract and
be displayed as the dominant bacteria within the feces in this model of
antibiotic-ablation of the intestinal microbiome. It is possible for

bacteria present in food to modulate intestinal microbiome studies. The
57

results of our study have paved the way for potential future studies of
whether and/or to what extent food-derived, non-viable bacteria can
alter intestinal physiology.
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